Search research articles
Contact Us
Filters
Showing results (1-10 of 78) with videos related to
Page
of 8
Sort By:
JAMA Oncology
|
July 17, 2015
JAMA Oncology Patient Page. Malignant Pleural Effusions
Howard Jack West
Frontiers in Oncology
|
October 26, 2020
Telemedicine in Oncology: Delivering on an Overdue Promise in the COVID-19 Era
Howard Jack West
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 3, 2016
Can We Define and Reach Precise Goals for Precision Medicine in Cancer Care?
Howard Jack West
JCO Oncology Practice
|
June 24, 2020
Jarring Discordance Between Idealized and Real-World Management in Stage III Non-Small-Cell Lung Cancer
Howard Jack West
JAMA Oncology
|
September 25, 2015
The Slippery Slope of Broadening Treatment Eligibility and Weak End Points: Defending the Oligo in Oligometastatic Non-Small-Cell Lung Cancer
Howard Jack West
Clinical Lung Cancer
|
October 8, 2009
The role for surgery in stage III non-small-cell lung cancer: can we reliably select the right patients?
Howard Jack West
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2013
Patients with advanced non-small-cell lung cancer and marginal performance status: walking the tight rope towards improved survival
Howard Jack West
JAMA Oncology
|
January 6, 2017
Bringing Adjuvant Chemotherapy for Resected Non-Small-Cell Lung Cancer Into Real-world Practice-Better Late Than Never?
Howard Jack West
The Oncologist
|
July 2, 2013
Practicing in partnership with Dr. Google: the growing effect of social media in oncology practice and research
Howard Jack West
JAMA Oncology
|
January 7, 2021
When the Signal From Phase 2 Research Should Be a Warning Sign
Howard Jack West
Page
of 8
Search research articles
Search
Showing results (1-10 of 78) with videos related to
Sort By:
Page
of 8
JAMA Oncology
|
July 17, 2015
JAMA Oncology Patient Page. Malignant Pleural Effusions
Howard Jack West
Frontiers in Oncology
|
October 26, 2020
Telemedicine in Oncology: Delivering on an Overdue Promise in the COVID-19 Era
Howard Jack West
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 3, 2016
Can We Define and Reach Precise Goals for Precision Medicine in Cancer Care?
Howard Jack West
JCO Oncology Practice
|
June 24, 2020
Jarring Discordance Between Idealized and Real-World Management in Stage III Non-Small-Cell Lung Cancer
Howard Jack West
JAMA Oncology
|
September 25, 2015
The Slippery Slope of Broadening Treatment Eligibility and Weak End Points: Defending the Oligo in Oligometastatic Non-Small-Cell Lung Cancer
Howard Jack West
Clinical Lung Cancer
|
October 8, 2009
The role for surgery in stage III non-small-cell lung cancer: can we reliably select the right patients?
Howard Jack West
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2013
Patients with advanced non-small-cell lung cancer and marginal performance status: walking the tight rope towards improved survival
Howard Jack West
JAMA Oncology
|
January 6, 2017
Bringing Adjuvant Chemotherapy for Resected Non-Small-Cell Lung Cancer Into Real-world Practice-Better Late Than Never?
Howard Jack West
The Oncologist
|
July 2, 2013
Practicing in partnership with Dr. Google: the growing effect of social media in oncology practice and research
Howard Jack West
JAMA Oncology
|
January 7, 2021
When the Signal From Phase 2 Research Should Be a Warning Sign
Howard Jack West
Page
of 8